Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

May 2, 2016

Edward Fox from the MS Clinic of Central Texas: Alemtuzumab’s Long-Term Studies Show Efficacy for Multiple Sclerosis Treatment

  • Multiple Sclerosis Videos
    /
                                       …
Multiple Sclerosis Videos

May 1, 2016

Lyme disease vs. multiple sclerosis (MS): Differences in symptoms, causes, and treatment

  • MS Research Study and Reports
    /
  • Multiple Sclerosis (MS) Symptoms
    /
                                       …
MS Research Study and Reports

May 1, 2016

A Way Forward in Treating Primary-Progressive Multiple Sclerosis?

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
                                       …
MS Research Study and Reports

May 1, 2016

Biogen, AbbVie multiple sclerosis drug wins EU green light

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
                                       …
MS Drug Therapies

May 1, 2016

MS Town Hall Meeting in Glenarden, MD – The Evolution of MS Care

  • Facts of MS
    /
  • MS Educational Programs
    /
  • MS Views and News
    /
  • Multiple Sclerosis
    /
============================================================================= Registration required. To Attend, RSVP using the link showing above   This event has limited seating      …
Facts of MS

May 1, 2016

ClinicSpeak & NeuroSpeak: sequencing DMTs switching from natalizumab to alemtuzumab

  • Lemtrada
    /
  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • Tysabri
    /
                                       …
Lemtrada

May 1, 2016

ClinicSpeak: natalizumab or alemtuzumab?

  • Lemtrada
    /
  • Multiple Sclerosis
    /
  • Tysabri
    /
                                       …
Lemtrada

April 29, 2016

At-Home ‘Brain Training’ Program for MS Patients Reported to Improve Cognitive Skills by 29%

  • Multiple Sclerosis (MS) Symptoms
    /
                                       …
Multiple Sclerosis (MS) Symptoms

April 29, 2016

Promising Phase 1 Trial Results of Stem Cell Therapy in Progressive MS Patients Being Presented at AAN Meeting

  • Multiple Sclerosis
    /
  • SPMS-PPMS News
    /
  • Stem Cell Related
    /
                                       …
Multiple Sclerosis

April 29, 2016

Sanofi Genzyme Presenting New Data on Lemtrada’s Beneficial Effects, Drawn from RRMS Extension Study, at AAN 2016

  • Lemtrada
    /
  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
                                       …
Lemtrada

Categories

Latest Blog Posts